3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
2
Observational
1
Sponsor
Cancer Type
Other
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Prostatic Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Metabolic Syndrome
1
Metabolic Diseases
1
Eunuchism
1
Diabetes Mellitus
1
Cardiovascular Diseases
1
Interventions
Surveys and Questionnaires
9
Blood Specimen Collection
5
naloxegol
3
Therapeutics
3
Observation
3
Interviews as Topic
3
Bariatric Surgery
3
naldemedine
2
exemestane
2
Tirzepatide
2
Tamoxifen
2
Psychiatric Rehabilitation
2
Paclitaxel
2
Hematologic Tests
2
Esophagectomy
2
Echocardiography
2
Carboplatin
2
Biopsy
2
BaseLine dental cement
2
Anastrozole
2
trametinib
1
sotorasib
1
semaglutide
1
selpercatinib
1
pembrolizumab
1
osimertinib
1
lorlatinib
1
dabrafenib
1
cemiplimab
1
bupropion hydrochloride, naltrexone hydrochoride drug combination
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Testosterone
×
Other
×
Clear all
NCT05773183
2023-03-17
MMetdMH
Royal College of Surgeons, Ireland
Unknown
60 enrolled